Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical management.
Aberrant expressions of micro-ribonucleic acids (miRs) are closely associated with the pathogenesis in many human cancers. In oesophageal adenocarcinomas, altered expressions of different sets of miRs are noted to be associated with the development of adenocarcinoma from Barrett's oesophagus. In different studies, miRs such as miR-192, miR-196 and miR-21 were frequently noted to up-regulated whereas miR-203, miR-205 and miR-let-7 were commonly down-regulated during the development of Barrett's oesophagus to oesophageal adenocarcinoma. In addition, changes in the expression of miRs are associated with the predication of metastasis, prognosis and response to chemo-radiation in the patients with oesophageal adenocarcinoma. Experimental studies in manipulating the miRs in cancer cell lines could provide hints for therapeutics for the cancer. However, the number of studies reported on these aspects of oesophageal adenocarcinoma was limited and the miRs noted needed to be confirmed by additional studies. Overall, the mechanisms of involvements of miRs in pathogenesis and progression of oesophageal adenocarcinoma are complex. Although miRs have the potential to act as prognostic and clinical biomarkers for cancer therapy in oesophageal adenocarcinoma, more works in larger populations and clinical trials are needed to validate these clinical implications.
Cancer Molecular Pathology, School of Medicine and Menzies Health Institute Queensland Institute, Griffith University, Gold Coast, Queensland, Australia.
Moein
M
Amin
Cancer Molecular Pathology, School of Medicine and Menzies Health Institute Queensland Institute, Griffith University, Gold Coast, Queensland, Australia; Pathology Queensland, Gold Coast University Hospital, Gold Coast, Queensland, Australia. Electronic address: a.lam@griffith.edu.au.
Alfred King-yin
AK
Lam
D063646:Carcinogenesis / Q000378:metabolism*; D002277:Carcinoma / Q000175:diagnosis / Q000378:metabolism* / Q000628:therapy; D004938:Esophageal Neoplasms / Q000175:diagnosis / Q000378:metabolism* / Q000628:therapy; D006801:Humans; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism*
D035683:MicroRNAs
Metastases; Micro-RNA; Oesophageal adenocarcinoma; Prognosis